Introduction
| DAB1 Gene | |
|---|---|
| **Gene Symbol** | DAB1 |
| **Full Name** | Disabled-1 |
| **Chromosomal Location** | 1p32-p31 |
| **NCBI Gene ID** | 1600 |
| **Ensembl ID** | ENSG00000170522 |
| **UniProt ID** | D3DX7A |
| **OMIM** | 603448 |
| **Protein Name** | Disabled-1 (DAB1) |
| **Molecular Weight** | ~80 kDa (625 amino acids) |
| **Subcellular Localization** | Cytoplasm, postsynaptic densities |
| **Protein Family** | Disabled family |
| Approach | Status |
| Small molecule modulators | Research |
| Gene therapy | Preclinical |
| Peptide agonists | Research |
| Associated Diseases | ALS, ALZHEIMER, Als, Alzheimer, Autism |
| KG Connections | 86 edges |
DAB1 encodes Disabled-1, an essential adaptor protein in the Reelin signaling pathway that controls neuronal migration and brain development. This page provides information about its structure, function, and role in neurological disorders. 1DAB1 in brain development (2020)Open reference
Overview
flowchart TD
DAB1["DAB1"] -->|"component of"| Reelin_Signaling_Pathway["Reelin Signaling Pathway"]
DAB1["DAB1"] -->|"expressed in"| superficial_dorsal_horn["superficial dorsal horn"]
DAB1["DAB1"] -->|"interacts with"| REELIN["REELIN"]
DAB1["DAB1"] -->|"mediates"| dI5_neuron_migration["dI5 neuron migration"]
DAB1["DAB1"] -->|"involved in"| Reelin_signaling_pathway["Reelin signaling pathway"]
DAB1["DAB1"] -->|"involved in"| Reelin_Signalling_Pathway["Reelin Signalling Pathway"]
DAB1["DAB1"] -->|"contributes to"| lamina_V["lamina V"]
DAB1["DAB1"] -->|"promotes"| cytoskeletal_stability["cytoskeletal_stability"]
DAB1["DAB1"] -->|"interacts with"| Ms["Ms"]
DAB1["DAB1"] -->|"interacts with"| Als["Als"]
DAB1["DAB1"] -->|"regulates"| Schizophrenia["Schizophrenia"]
DAB1["DAB1"] -->|"regulates"| Epilepsy["Epilepsy"]
DAB1["DAB1"] -->|"regulates"| Alzheimer["Alzheimer"]
DAB1["DAB1"] -->|"regulates"| Autism["Autism"]
style DAB1 fill:#4fc3f7,stroke:#333,color:#000DAB1 (Disabled-1) is a key intracellular adaptor protein in the Reelin signaling pathway. The Reelin-DAB1 pathway is crucial for proper brain development, cortical layer formation, and synaptic plasticity. DAB1 mediates the effects of Reelin on neuronal positioning, dendrite maturation, and long-term potentiation. 2Reelin and DAB1 in synaptic plasticity (2019)Open reference
Gene Information
Protein Overview
Domain Structure
-
N-terminal domain: Protein interactions
-
Proline-rich region: SH3 domain binding
-
Phosphotyrosine-binding (PTB) domain: Reelin receptor binding
-
Multiple tyrosine phosphorylation sites: Signaling regulation
Normal Function
Reelin Signaling
-
Binds to Reelin receptors (ApoER2, VLDLR)
-
Mediates Reelin-induced neuronal positioning
-
Controls cortical layer formation
-
Regulates dendrite maturation
Neuronal Development
-
Essential for brain lamination
-
Controls neuronal migration
-
Regulates spine development
-
Supports synaptic formation
Synaptic Plasticity
-
Modulates NMDA receptor function
-
Regulates AMPA receptor trafficking
-
Supports LTP and learning
-
Memory consolidation role
Disease Associations
Alzheimer’s Disease
-
DAB1 expression altered in AD brain
-
Reelin-DAB1 pathway impaired
-
May affect amyloid processing
-
Possible therapeutic target
Schizophrenia
-
Genetic association with schizophrenia
-
Altered DAB1 expression
-
Neurodevelopmental implications
-
Synaptic dysfunction link
Epilepsy
-
DAB1 dysregulation in epilepsy
-
Possible seizure mechanisms
-
Developmental origins
Other Disorders
-
Autism: Possible neurodevelopmental role
-
Intellectual disability: Developmental pathways
Expression
-
Brain regions: High expression in cortex, hippocampus, cerebellum
-
Cellular expression: Neurons, especially pyramidal cells
-
Subcellular: Cytoplasm, dendritic compartments, postsynaptic densities
-
Expression pattern: High during development, maintained in adult
Therapeutic Targeting
Animal Models
-
Knockout mice: Severe brain lamination defects
-
Reeler mice: Natural DAB1 pathway mutation
-
Transgenic models: Conditional knockouts
Interacting Proteins
-
RELN: Reelin - extracellular ligand
-
VLDLR: Very low-density lipoprotein receptor
-
ApoER2: Apolipoprotein E receptor 2
-
FYN: Src family kinase
-
NMDA receptors: Synaptic signaling
-
PI3K: Downstream signaling
Signaling Cascade
-
Reelin binds to ApoER2/VLDLR
-
DAB1 recruited to receptors
-
DAB1 phosphorylation by Src family kinases
-
Activation of PI3K/Akt pathway
-
Regulation of microtubule dynamics
-
Control of neuronal positioning
Research Directions
-
Understanding pathway dysregulation in disease
-
Therapeutic modulation approaches
-
Biomarker development
-
Clinical translation
See Also
Background
The study of Dab1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
-
PubMed - Biomedical literature
-
Alzheimer’s Disease Neuroimaging Initiative - Research data
-
Allen Brain Atlas - Brain gene expression data
References
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.